Metoclopramide-induced acute dyskinesia with brain infarction: a case report-Reference-Cited by-同舟云学术

Metoclopramide-induced acute dyskinesia with brain infarction: a case report

Published:2023 Issue:1 Volume:45 Page:51-55
ISSN:0912-0726
Container-title:Japanese Journal of Stroke
language:en
Short-container-title:Jpn. J. Stroke

Author:

Iwamoto Munenori¹,Otsuka Yoshihisa¹,Tsuji Asato¹,Imura Jun²,Shiomi Ryoji²,Okamura Yusuke²

Affiliation:

1. Division of Internal Medicine, Hyogo Prefectural Tamba Medical Center

2. Division of Neurosurgery, Hyogo Prefectural Tamba Medical Center

Publisher

Japan Stroke Society

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jstroke/45/1/45_11046/_pdf

Reference16 articles.

1. 1） Shigematsu K, Shimamura O, Nakano H, et al.: Vomiting should be a prompt predictor of stroke outcome. Emerg Med J 30: 728–731, 2013

2. 2）武井大輔，成田　年，塩川満ら：嘔気・嘔吐の薬物療法．日緩和医療薬誌 2: 111–117, 2009

3. 3） European Medicine Agency: European Medicines Agency recommends changes to the use of metoclopramide Changes aim mainly to reduce the risk of neurological side effects. 2013. https://www.ema.europa.eu/en/documents/referral/metoclopramide-article-31-referral-european-medicines-agency-confirms-changes-use-metoclopramide_en.pdf（アクセス日：2022年5月24日）

4. 4） U.S.Food & Drug Administration: Reglan (metoclopramide) tablets, ODT (Orally Disintegrating Tablets), and injection. http://wayback.archive-it.org/7993/20161022205258/http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm170934.htm（アクセス日：2022年5月24日）

5. 5） Moos DD, Hansen DJ: Metoclopramide and extrapyramidal symptoms: a case report. J Perianesth Nurs 23: 292–299, 2008